TuesdayJan 31, 2017 1:00 pm

Americas Silver Corp. (USAPF) Starts Presentation at NobleCon13

Americas Silver (OTC: USAPF) is a Canadian-based junior silver producer with assets in the Americas and a strong operating platform. Annual production for 2016 is expected to be 5.0 million-5.6 million silver equivalent ounces. The company has two established producing mines, a third mine in construction, and an advanced stage exploration project. Construction has commenced on the San Rafael project located in Mexico that will increase the company's silver equivalent production to 7.0 million-7.5 million ounces between $7 and $8 silver all in sustaining costs in 2018. For more information, visit the company’s website at www.americassilvercorp.com. About NetworkNewsWire NetworkNewsWire (NNW)…

Continue Reading

TuesdayJan 31, 2017 1:00 pm

BioSpecifics Technologies Corp. (NASDAQ: BSTC) Starts Presentation at NobleCon13

BioSpecifics Technologies (NASDAQ: BSTC) is a biopharmaceutical company that engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren’s contracture and Peyronie’s disease under the XIAFLEX brand in Canada and Australia, as well as under XIAPEX brand name in Europe. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, and plantar fibromatosis, as well as for the treatment of human lipoma and uterine fibroids. BioSpecifics is also involved in the development of other clinical indications for which collagenase…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Marlin Gold Mining Ltd. (MLNGF) Starts Presentation at NobleCon13

Marlin Gold Mining (OTC: MLNGF) explores for, develops, and produces gold in the Americas. The company also explores for silver ores. It principal project is the Taunus deposit that is held by the La Trinidad property located in Sinaloa, Mexico. The company was formerly known as Oro Mining Ltd. and changed its name to Marlin Gold Mining Ltd. in November 2012. Marlin Gold Mining Ltd. was incorporated in 2000 and is headquartered in Vancouver, Canada. For more information, visit the company’s website at www.marlingold.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Del Mar Pharmaceuticals, Inc. (NASDAQ: DMPI) Starts Presentation at NobleCon13

Del Mar Pharmaceuticals (NASDAQ: DMPI) is a pharmaceutical company that develops and commercializes new cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments. The company's lead drug in development, VAL-083, is currently undergoing clinical trials in the U.S. as a potential treatment for refractory glioblastoma multiforme. VAL-083 has been extensively studied by U.S. National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Quest Resource Holding Corp. (NASDAQ: QRHC) Starts Presentation at NobleCon13

Quest Resource Holding (NASDAQ: QRHC) provides management programs to reuse, recycle and dispose various waste streams and recyclables in the United States. The company offers recycling management services for motor oil, oil filters, scrap tires, grease and cooking oil, and expired food products; and various other materials, such as glass, cardboards, paper, metals, plastic oil bottles, hazardous materials, HDPE plastics, construction debris, batteries, mercury, lights, regulated medical waste, electronics, parts cleaners, used absorbents, solid waste, and industrial cleaning products. It also provides landfill diversion services and environmental certification services. For more information, visit the company’s website at www.qrhc.com. About NetworkNewsWire…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Onconova Therapeutics, Inc. (NASDAQ: ONTX) Starts Presentation at NobleCon13

Onconova Therapeutics (NASDAQ: ONTX) is a phase III stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in clinical trials and several active pre-clinical programs. Advanced clinical trials are aimed at unmet medical needs of patients with myelodysplastic syndromes (MDS). For more information, visit the company’s website at www.onconova.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and…

Continue Reading

TuesdayJan 31, 2017 12:00 pm

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Starts Presentation at NobleCon13

Interpace Diagnostics Group (NASDAQ: IDXG) develops and commercializes molecular diagnostic tests for physicians and patients to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers in the United States. The company offers PancraGen, a diagnostic test designed for determining risk of malignancy in pancreatic cysts; ThyGenX, a sequencing test designed to assist physicians in distinguishing between benign and malignant genotypes in indeterminate thyroid nodules; ThyraMIR, a novel microRNA gene expression classifier; and PathFinder TG Barrett's, an esophageal cancer risk classifier. For more information, visit the company’s website at www.pdi-inc.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and…

Continue Reading

TuesdayJan 31, 2017 12:00 pm

Excel Corp. (EXCC) Starts Presentation at NobleCon13

Excel Corporation (OTC: EXCC) provides integrated financial and transaction processing services to small and medium-sized businesses in the United States. The company provides an integrated suite of third-party merchant payment processing services and related proprietary software enabling products that deliver credit and debit card-based Internet payments processing solutions to small and mid-sized merchants operating in physical business environments, on the internet, and in retail settings requiring wired and wireless mobile payment solutions. For more information, visit the company’s website at www.excelcorpusa.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…

Continue Reading

TuesdayJan 31, 2017 12:00 pm

Bionik Laboratories Corp. (BNKL) Starts Presentation at NobleCon13

Bionik Laboratories (OTC: BNKL) is a medical device and robotics company focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders. It specializes in designing, developing and commercializing physical rehabilitation technologies, prosthetics and assisted robotic products. The company offers InMotion Systems, which include the InMotion ARM that allows clinicians to deliver sensormotor therapy to the shoulder and elbow to develop new neural pathways; InMotion Hand, an add-on module to be used with the InMotion ARM; InMotion WRIST, which enables clinicians to deliver optimum intensive sensorimotor wrist and forearm therapy to patients with neurological conditions;…

Continue Reading

TuesdayJan 31, 2017 11:30 am

OncoSec Medical, Inc. (NASDAQ: ONCS) Starts Presentation at NobleCon13

OncoSec Medical (NASDAQ: ONCS) designs, develops and commercializes gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer in the United States. Its lead product candidate is the ImmunoPulse IL-12, which is in phase II clinical trial for various indications, including metastatic melanoma and triple negative breast cancer. ImmunoPulse is an electroporation delivery device used in combination with the company’s therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor. For more information, visit the company’s website at www.oncosec.com. About…

Continue Reading

Contact us: 212.418.1217